Clinical Spectrum of Biopsy Proven Mitochondrial Myopathy.

Autor: Menon D; Department of Neurology, SCTIMST, Trivandrum, Kerala, India., Nair SS; Department of Neurology, SCTIMST, Trivandrum, Kerala, India., Radhakrishnan N; Department of Pathology, SCTIMST, Trivandrum, Kerala, India., Saraf UU; Department of Neurology, SCTIMST, Trivandrum, Kerala, India., Nair M; Department of Neurology, SCTIMST, Trivandrum, Kerala, India.
Jazyk: angličtina
Zdroj: Neurology India [Neurol India] 2023 Nov-Dec; Vol. 71 (6), pp. 1192-1196.
DOI: 10.4103/0028-3886.391399
Abstrakt: Objectives: Clinical spectrum of mitochondrial myopathy extends beyond chronic progressive external ophthalmoplegia (CPEO). While information on encephalomyopathies is abundant, clinical data on predominant myopathic presentation of mitochondrial disorders are lacking.
Materials and Methods: Clinical, electrophysiological, biochemical, and follow-up data of patients with predominant myopathic presentation and muscle biopsy confirmed primary mitochondrial myopathy was obtained. We excluded known syndromes of mitochondrial cytopathies and encephalomyopathies.
Results: Among 16 patients, 7 had CPEO, 4 had CPEO with limb-girdle muscle weakness (LGMW), and 5 had isolated LGMW. Systemic features included seizures with photosensitivity (n = 3), diabetes (n = 1), cardiomyopathy (n = 1), and sensorineural hearing loss (n = 1) and were more common in isolated LGMW. Elevated serum creatine kinase (CK) and lactate levels and electromyography (EMG) myopathic potentials were more frequent with LGMW. During follow-up, LGMW had more severe progression of weakness.
Conclusion: We identified three subsets of mitochondrial myopathy with distinct clinical features and evolutionary patterns. Isolated LGMW was seen in 30% of patients and would represent severe end of the spectrum.
Competing Interests: None
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje